1. Epigenetics Metabolic Enzyme/Protease
  2. Methionine Adenosyltransferase (MAT)
  3. ZS34

ZS34 is a potent, orally active, and selective MAT2A inhibitor with an IC50 of 13.7 nM, displaying minimal hERG and UGT1A1 liabilities. ZS34 selectively suppresses the growth of methylthioadenosine phosphorylase (MTAP)-deficient cancer cells by inhibiting SAM synthesis, reducing SDMA levels, and inducing DNA damage. ZS34 exhibits antitumor efficacy in a HCT116 MTAP-/- xenograft mouse model. ZS34 can be used for the research of MTAP-deficient cancer.

For research use only. We do not sell to patients.

ZS34

ZS34 Chemical Structure

CAS No. : 3106086-17-0

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

ZS34 is a potent, orally active, and selective MAT2A inhibitor with an IC50 of 13.7 nM, displaying minimal hERG and UGT1A1 liabilities. ZS34 selectively suppresses the growth of methylthioadenosine phosphorylase (MTAP)-deficient cancer cells by inhibiting SAM synthesis, reducing SDMA levels, and inducing DNA damage. ZS34 exhibits antitumor efficacy in a HCT116 MTAP-/- xenograft mouse model. ZS34 can be used for the research of MTAP-deficient cancer[1].

IC50 & Target[1]

MAT2A

13.7 nM (IC50)

In Vitro

ZS34 (10 days) inhibits the proliferation of MTAP deficiency cells (NCI-H838, NCI-H1437, MCF-7, MDA-MB-231 and MIA PaCa-2 cells) with IC50s of 1.70, 386, 38.1, 37.2, and 115 nM, respectively, exhibiting selectivity over MTAP proficiency cells (A-375, AsPC-1, DU145, NCI-H460 and NCI-H520) with IC50s >10000 nM[1].
ZS34 (10 days) exhibits potent antiproliferative effects against HCT116 MTAP-null cells (IC50 = 124 nM) but weak activity against WT HCT116 cells (IC50 > 10000 nM), demonstrating excellent selectivity inhibition with a selective indices (SI) exceeding 80.6[1].
ZS34 (0-10 μM; 96 h) selectively induces DNA damage in MTAP-deficient HCT116 cells through MAT2A inhibition[1].
ZS34 binds to the allosteric site of the MAT2A dimer, forming hydrogen bonds with Arg313 and a coordinated water molecule, and engaging in π-π stacking with Phe20, Trp274, and Phe18, while its ortho-methyl group participates in a CH-π interaction with Phe333[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: HCT116 (MTAP-/-) and HCT116 (WT)
Concentration: 0, 0.1, 1 μM
Incubation Time: 96 h
Result: Induced a dose-dependent decrease in the SDMA level, in HCT116 MTAP-/- cells, but not in HCT116 WT cells.
Induced a marked increase in γH2AX levels, a marker of DNA damage, in HCT116 MTAP-/- cells, but not in HCT116 WT cells.

Immunofluorescence[1]

Cell Line: HCT116 (MTAP-/-) and HCT116 (WT)
Concentration: 0.1, 1, 10 μM
Incubation Time: 96 h
Result: led to a marked increase in γH2AX levels in HCT116 MTAP-/-cells compared to the control, but not in HCT116 WT cells.
Parmacokinetics
Species Dose Route T1/2 Cmax AUCinf F Tmax MRTINF_obs ClF_obs Vss_obs
Mice[1] 10 mg/kg p.o. 2.53 h 8049 ng/mL 17549 ng·h/mL 148 % 0.33 h 2.35 h / /
Mice[1] 5 mg/kg i.v. 1.02 h / 5946 ng·h/mL / / 0.88 h 15.6 mL/min/kg 792 mL/kg
In Vivo

ZS34 (10 and 30 mg/kg, p.o., daily for 30 days) demonstrats robust in vivo antitumor efficacy and a favorable safety profile in the HCT116 MTAP-/- xenograft moues model[1].
ZS34 (400 mg/kg, p.o., single dose) shows no obvious toxicity in mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female ALB/c nude mice subcutaneously inoculated with HCT116 MTAP-/- cells[1]
Dosage: 10, 30 mg/kg
Administration: p.o., daily for 30 days
Result: Significantly suppressed tumor growth, with tumor growth inhibition (TGI) values of 57.3% and 89.0% at 10 and 30 mg/kg, respectively.
Showed a tendency to cause tumor regression at 30 mg/kg.
Reduced SAM levels in tumors.
Showed no significant body weight loss compared to control.
Animal Model: ICR mice[1]
Dosage: 400 mg/kg
Administration: p.o., single dose
Result: Was well tolerated at this high dose.
Molecular Weight

339.78

Formula

C18H14ClN3O2

CAS No.
SMILES

O=C1N(C2=C(C(NC)=N1)C3=C(C(Cl)=C2)C=CO3)C4=CC=CC=C4C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
ZS34
Cat. No.:
HY-179622
Quantity:
MCE Japan Authorized Agent: